SMMT
NASDAQ · Biotechnology
Summit Therapeutics Inc
$15.54
-0.06 (-0.38%)
Performance
1D
—
1W
—
1M
—
3M
-14.33%
6M
-25.82%
1Y
-23.22%
YTD
-11.30%
Open$15.43
Previous Close$15.60
Day High$16.13
Day Low$15.36
52W High$36.91
52W Low$13.83
Volume—
Avg Volume2.11M
Market Cap11.58B
P/E Ratio—
EPS$-1.01
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$16.75
Below
SMA 200
$20.83
Below
RSI (14)
54
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
23 analysts
Price Target
+1,161.8% upside
Current
$15.54
$15.54
Target
$196.08
$196.08
$141.53
$196.08 avg
$244.39
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.10B | 1.08B | 883.89M |
| Net Income | 169.72M | 168.86M | 142.65M |
| Profit Margin | 15.4% | 15.6% | 16.1% |
| EBITDA | 286.46M | 306.19M | 235.37M |
| Free Cash Flow | 170.10M | 157.58M | 108.43M |
| Rev Growth | -3.6% | +10.5% | -9.8% |
| Debt/Equity | 1.16 | 1.05 | 1.18 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |